Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Pettersson, Ulrika Sofia ^a   Christoffersson, Gustaf ^a   Massena, Sara ^a   Ahl, David ^a   Jansson, Leif ^a   Henriksnäs, Johanna ^a   Phillipson, Mia ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GLUCOSE; INSULIN; MACROPHAGE INFLAMMATORY PROTEIN 2; CXCL2 CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; CONTROLLED STUDY; CREMASTER MUSCLE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; LIPID DIET; MALE; MICROSCOPY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS; ANIMAL; BLOOD; C57BL MOUSE; CELL ADHESION; CELL COUNT; CELL MOTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MICROBIOLOGY; PHAGOCYTE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BLOOD GLUCOSE; CELL ADHESION; CELL COUNT; CELL MOVEMENT; CHEMOKINE CXCL2; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HYPERGLYCEMIA; INFLAMMATION; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; PHAGOCYTES; STAPHYLOCOCCUS AUREUS;

EID: 79960708241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022480     Document Type: Article

References (33)

1. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986.
2. Zimmet P, Alberti KG, Shaw J, (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
3. Sjöholm A, Nyström T, (2006) Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 22: 4-10.
4. Dandona P, Aljada A, Bandyopadhyay A, (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7.
5. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, et al. (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397-1403.
6. Wheat LJ, (1980) Infection and diabetes mellitus. Diabetes Care 3: 187-197.
7. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, et al. (1982) Infection and diabetes: the case for glucose control. Am J Med 72: 439-450.
8. Hadi HA, Suwaidi JA, (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3: 853-876.
9. Calhoun JH, Overgaard KA, Stevens CM, Dowling JP, Mader JT, (2002) Diabetic foot ulcers and infections: current concepts. Adv Skin Wound Care 15: 31-42; quiz 44-35.
10. Ley K, Laudanna C, Cybulsky MI, Nourshargh S, (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
11. Springer TA, (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
12. Petri B, Phillipson M, Kubes P, (2008) The physiology of leukocyte recruitment: an in vivo perspective. J Immunol 180: 6439-6446.
13. Massena S, Christoffersson G, Hjertstrom E, Zcharia E, Vlodavsky I, et al. (2010) A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood 116: 1924-1931.
14. Dahlgren C, Karlsson A, (1999) Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14.
15. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme J, (1991) Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes 40: 1267-1273.
16. Sannomiya P, Oliveira MA, Fortes ZB, (1997) Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study. Br J Pharmacol 122: 894-898.
17. Cruz JW, Oliveira MA, Hohman TC, Fortes ZB, (2000) Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes. Eur J Pharmacol 391: 163-174.
18. Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, et al. (1996) Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93: 161-167.
19. Sampson MJ, Davies IR, Brown JC, Ivory K, Hughes DA, (2002) Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22: 1187-1193.
20. Shahin RD, Engberg I, Hagberg L, Svanborg Eden C, (1987) Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol 138: 3475-3480.
21. Rich J, Lee JC, (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54: 2904-2910.
22. Anderson MS, Bluestone JA, (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
23. Freedman SF, Hatchell DL, (1992) Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes. Exp Eye Res 55: 767-773.
24. Ptak W, Klimek M, Bryniarski K, Ptak M, Majcher P, (1998) Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals. Clin Exp Immunol 114: 13-18.
25. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, et al. (2000) Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85: 2970-2973.
26. Gupta A, Tripathi AK, Tripathi RL, Madhu SV, Banerjee BD, (2007) Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys 44: 373-378.
27. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34.
28. Jakelic J, Kokic S, Hozo I, Maras J, Fabijanic D, (1995) Nonspecific immunity in diabetes: hyperglycemia decreases phagocytic activity of leukocytes in diabetic patients. Med Arh 49: 9-12.
29. Bohman S, King AJ, (2008) Islet alpha cell number is maintained in microencapsulated islet transplantation. Biochem Biophys Res Commun 377: 729-733.
30. Rerup C, Tarding F, (1969) Streptozotocin- and alloxan-diabetes in mice. Eur J Pharmacol 7: 89-96.
31. Cara DC, Kaur J, Forster M, McCafferty DM, Kubes P, (2001) Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J Immunol 167: 6552-6558.
32. Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, et al. (2006) Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med 203: 2569-2575.
33. Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, et al. (2008) PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. Nat Immunol 9: 743-752.